We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$796M
AUM Growth
-$26.8M
Cap. Flow
-$2.58M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.24%
Holding
141
New
8
Increased
58
Reduced
61
Closed
1

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$4.93M
2
LLY icon
Eli Lilly
LLY
+$3.48M
3
BKNG icon
Booking.com
BKNG
+$1.75M
4
DHI icon
D.R. Horton
DHI
+$1.73M
5
DY icon
Dycom Industries
DY
+$1.43M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.93M
2
DIS icon
Walt Disney
DIS
+$2.91M
3
T icon
AT&T
T
+$2.64M
4
DLTR icon
Dollar Tree
DLTR
+$2.46M
5
CVS icon
CVS Health
CVS
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 17.54%
2 Healthcare 14.51%
3 Financials 12.75%
4 Consumer Discretionary 10.61%
5 Energy 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
26
NextEra Energy
NEE
$181B
$10.8M 1.36%
189,089
-209
-0.1% -$14.5K
CNI icon
27
Canadian National Railway
CNI
$76.1B
$10.5M 1.32%
96,905
-5,599
-5% -$642K
BKNG icon
28
Booking.com
BKNG
$149B
$10.3M 1.29%
83,400
+14,475
+21% +$1.75M
PFE icon
29
Pfizer
PFE
$143B
$9.99M 1.26%
301,307
-19,941
-6% -$705K
ACN icon
30
Accenture
ACN
$101B
$9.97M 1.25%
32,476
-1,023
-3% -$322K
PAYX icon
31
Paychex
PAYX
$41.9B
$9.31M 1.17%
80,734
+1,647
+2% +$198K
SLB icon
32
SLB Ltd
SLB
$73.2B
$9.24M 1.16%
158,526
+10,628
+7% +$616K
STE icon
33
Steris
STE
$22.7B
$8.97M 1.13%
40,899
+35
+0.1% +$7.92K
GPN icon
34
Global Payments
GPN
$23.6B
$8.08M 1.01%
69,982
+3,465
+5% +$412K
ABT icon
35
Abbott
ABT
$185B
$7.93M 1%
81,887
-7,728
-9% -$812K
KMI icon
36
Kinder Morgan
KMI
$69.9B
$7.78M 0.98%
469,052
-33,501
-7% -$578K
CTVA icon
37
Corteva
CTVA
$50.9B
$7.57M 0.95%
148,041
-5,107
-3% -$270K
DEO icon
38
Diageo
DEO
$49.2B
$7.52M 0.94%
50,377
+2,240
+5% +$375K
FTNT icon
39
Fortinet
FTNT
$120B
$7.36M 0.92%
125,422
+5,032
+4% +$333K
NKE icon
40
Nike
NKE
$63.3B
$6.77M 0.85%
70,829
+2,261
+3% +$233K
BHP icon
41
BHP
BHP
$212B
$6.43M 0.81%
113,050
-34,129
-23% -$2M
URI icon
42
United Rentals
URI
$69.5B
$6.3M 0.79%
14,181
-659
-4% -$302K
EXP icon
43
Eagle Materials
EXP
$6.59B
$6.25M 0.79%
37,534
+4,541
+14% +$825K
IQV icon
44
IQVIA
IQV
$38.4B
$5.84M 0.73%
29,668
+265
+0.9% +$57.5K
CAH icon
45
Cardinal Health
CAH
$55.2B
$5.77M 0.72%
66,451
+13,858
+26% +$1.25M
DIS icon
46
Walt Disney
DIS
$170B
$5.24M 0.66%
64,702
-34,116
-35% -$2.91M
PLD icon
47
Prologis
PLD
$135B
$5.05M 0.63%
44,970
-728
-2% -$89.1K
CTAS icon
48
Cintas
CTAS
$81.6B
$5.03M 0.63%
41,832
-1,396
-3% -$174K
MA icon
49
Mastercard
MA
$500B
$4.86M 0.61%
+12,272
New +$4.93M
SWKS icon
50
Skyworks Solutions
SWKS
$9.22B
$4.84M 0.61%
49,111
-6,568
-12% -$699K

Similar funds

Callahan Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Callahan Advisors held 141 positions worth $796M, down 3.3% from $823M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Callahan Advisors's Q3 2023 filing shows 8 new, 58 increased, 61 reduced and 1 closed positions. Its largest new stake was Mastercard: 12,272 shares worth $4.86M. The largest sale was Bristol-Myers Squibb, an estimated $2.93M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Callahan Advisors's largest Q3 2023 buy was Mastercard: 12,272 shares worth $4.86M.
  • Callahan Advisors added most to Eli Lilly in Q3 2023, an estimated $3.48M increase.
  • Callahan Advisors's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.93M.
  • Callahan Advisors fully exited Schwab US TIPS ETF in Q3 2023, selling an estimated $322K.
  • Callahan Advisors's ten largest holdings make up 33% of its $796M portfolio in Q3 2023.
  • Callahan Advisors opened 8 new positions and closed 1 in Q3 2023.
  • Callahan Advisors's portfolio value fell 3.3% quarter-over-quarter to $796M.

Based on Callahan Advisors's 13F filing for Q3 2023, filed 23 Oct 2023.